Literature DB >> 26468051

The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Adam T Waickman1, Joo-Young Park1, Jung-Hyun Park2.   

Abstract

Originally identified as the third subunit of the high-affinity IL-2 receptor complex, the common γ-chain (γc) also acts as a non-redundant receptor subunit for a series of other cytokines, collectively known as γc family cytokines. γc plays essential roles in T cell development and differentiation, so that understanding the molecular basis of its signaling and regulation is a critical issue in T cell immunology. Unlike most other cytokine receptors, γc is thought to be constitutively expressed and limited in its function to the assembly of high-affinity cytokine receptors. Surprisingly, recent studies reported a series of findings that unseat γc as a simple housekeeping gene, and unveiled γc as a new regulatory molecule in T cell activation and differentiation. Cytokine-independent binding of γc to other cytokine receptor subunits suggested a pre-association model of γc with proprietary cytokine receptors. Also, identification of a γc splice isoform revealed expression of soluble γc proteins (sγc). sγc directly interacted with surface IL-2Rβ to suppress IL-2 signaling and to promote pro-inflammatory Th17 cell differentiation. As a result, endogenously produced sγc exacerbated autoimmune inflammatory disease, while the removal of endogenous sγc significantly ameliorated disease outcome. These data provide new insights into the role of both membrane and soluble γc in cytokine signaling, and open new venues to interfere and modulate γc signaling during immune activation. These unexpected discoveries further underscore the perspective that γc biology remains largely uncharted territory that invites further exploration.

Entities:  

Keywords:  Alternative splicing; Homeostasis; JAK3; Signaling; Survival

Mesh:

Substances:

Year:  2015        PMID: 26468051      PMCID: PMC6315299          DOI: 10.1007/s00018-015-2062-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  140 in total

1.  Structural reorganization of the interleukin-7 signaling complex.

Authors:  Craig A McElroy; Paul J Holland; Peng Zhao; Jae-Min Lim; Lance Wells; Edward Eisenstein; Scott T R Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.

Authors:  K Sugamura; H Asao; M Kondo; N Tanaka; N Ishii; K Ohbo; M Nakamura; T Takeshita
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Priscila P Zenatti; Daniel Ribeiro; Wenqing Li; Linda Zuurbier; Milene C Silva; Maddalena Paganin; Julia Tritapoe; Julie A Hixon; André B Silveira; Bruno A Cardoso; Leonor M Sarmento; Nádia Correia; Maria L Toribio; Jörg Kobarg; Martin Horstmann; Rob Pieters; Silvia R Brandalise; Adolfo A Ferrando; Jules P Meijerink; Scott K Durum; J Andrés Yunes; João T Barata
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

4.  The cellular amount of the common gamma-chain influences spontaneous or induced cell proliferation.

Authors:  Stefania Amorosi; Ilaria Russo; Giada Amodio; Corrado Garbi; Laura Vitiello; Loredana Palamaro; Marsilio Adriani; Ilaria Vigliano; Claudio Pignata
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

5.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.

Authors:  T Miyazaki; A Kawahara; H Fujii; Y Nakagawa; Y Minami; Z J Liu; I Oishi; O Silvennoinen; B A Witthuhn; J N Ihle
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

6.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.

Authors:  S M Russell; J A Johnston; M Noguchi; M Kawamura; C M Bacon; M Friedmann; M Berg; D W McVicar; B A Witthuhn; O Silvennoinen
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

7.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

Authors:  J A Johnston; M Kawamura; R A Kirken; Y Q Chen; T B Blake; K Shibuya; J R Ortaldo; D W McVicar; J J O'Shea
Journal:  Nature       Date:  1994-07-14       Impact factor: 49.962

8.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

Authors:  Roza I Nurieva; Yeonseok Chung; Daehee Hwang; Xuexian O Yang; Hong Soon Kang; Li Ma; Yi-hong Wang; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2008-07-03       Impact factor: 31.745

9.  Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors.

Authors:  Christine M Smyth; Samantha L Ginn; Claire T Deakin; Grant J Logan; Ian E Alexander
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

Review 10.  Interleukin-4 and interleukin-13: their similarities and discrepancies.

Authors:  P Chomarat; J Banchereau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

View more
  31 in total

1.  CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans.

Authors:  Adam T Waickman; Davinna L Ligons; SuJin Hwang; Joo-Young Park; Vanja Lazarevic; Noriko Sato; Changwan Hong; Jung-Hyun Park
Journal:  Cytokine       Date:  2017-08-12       Impact factor: 3.861

Review 2.  IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Authors:  Christian Lundtoft; Julia Seyfarth; Marc Jacobsen
Journal:  Genes Immun       Date:  2020-01-13       Impact factor: 2.676

3.  RORγt limits the amount of the cytokine receptor γc through the prosurvival factor Bcl-xL in developing thymocytes.

Authors:  Davinna L Ligons; SuJin Hwang; Adam T Waickman; Joo-Young Park; Megan A Luckey; Jung-Hyun Park
Journal:  Sci Signal       Date:  2018-08-28       Impact factor: 8.192

4.  Remote control of γc expression by arginine methylation.

Authors:  Joo-Young Park; Jung-Hyun Park
Journal:  Nat Immunol       Date:  2018-11       Impact factor: 25.606

Review 5.  Demystifying the cytokine network: Mathematical models point the way.

Authors:  Penelope A Morel; Robin E C Lee; James R Faeder
Journal:  Cytokine       Date:  2016-12-03       Impact factor: 3.861

6.  Protein abundance of the cytokine receptor γc controls the thymic generation of innate-like T cells.

Authors:  Joo-Young Park; Hee Yeun Won; Devon T DiPalma; Changwan Hong; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

7.  The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells.

Authors:  Hilary R Keller; Hye Kyung Kim; Yuna Jo; Ronald E Gress; Changwan Hong; Jung-Hyun Park
Journal:  J Immunol       Date:  2020-05-11       Impact factor: 5.422

8.  Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.

Authors:  Asif Nashiry; Shauli Sarmin Sumi; Salequl Islam; Julian M W Quinn; Mohammad Ali Moni
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

9.  Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome.

Authors:  Brahim Belaid; Lydia Lamara Mahammed; Aida Mohand Oussaid; Melanie Migaud; Yasmine Khadri; Jean Laurent Casanova; Anne Puel; Nafissa Ben Halla; Reda Djidjik
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

10.  JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation.

Authors:  Lauren K Meyer; Katherine C Verbist; Sabrin Albeituni; Brooks P Scull; Rachel C Bassett; Alexa N Stroh; Heather Tillman; Carl E Allen; Michelle L Hermiston; Kim E Nichols
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.